Johnson & Johnson Expects 2024 Adjusted EPS Of $10.57–$10.72 Versus Consensus Of $10.66 And Prior Guidance Of $10.55–$10.75, With Adjusted Operational EPS Of $10.60–$10.75
Portfolio Pulse from Benzinga Newsdesk
Johnson & Johnson has updated its 2024 adjusted EPS forecast to $10.57–$10.72, aligning closely with the consensus estimate of $10.66 and slightly adjusting its prior guidance of $10.55–$10.75. The company also provided an adjusted operational EPS range of $10.60–$10.75.
April 16, 2024 | 10:26 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Johnson & Johnson narrows its 2024 adjusted EPS forecast to $10.57–$10.72, closely aligning with market expectations and slightly refining its previous guidance.
The adjustment in Johnson & Johnson's EPS forecast is minor, suggesting a stable financial outlook. The alignment with consensus estimates indicates that the market may have already anticipated this adjustment, likely resulting in a neutral short-term impact on JNJ's stock price. The slight refinement in guidance demonstrates the company's confidence in its financial performance, but since the change is minimal, it's unlikely to significantly sway investor sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100